Sanofi-Aventis U.S. LLC recalls Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-coun…
- Recall date
- June 12, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0926-2017
- FDA classification
- Class III
- Brand / firm
- Sanofi-Aventis U.S. LLC
- Sold / distributed
- Nationwide in the USA, Puerto Rico, and the United Kingdom.
Why it was recalled
Superpotent Drug: high out-of-specification result for magnesium.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.
Get recall alerts
Free email alert whenever Sanofi-Aventis U.S. LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sanofi-Aventis U.S. LLC